Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

A review of the management of antidepressant discontinuation symptoms

Open access
Wilson, Emma, Lader, Malcolm · 2015 · Therapeutic Advances in Psychopharmacology

Abstract

Strong evidence supports the existence of a discontinuation syndrome following the withdrawal of antidepressant medication, particularly second-generation antidepressants. The syndrome is a common phenomenon and guidance as to best avoid the symptoms is essential for both practitioners and patients. The current study reviewed the available literature on the best methods of discontinuation for antidepressants in order to avoid or prevent the occurrence of any unpleasant side effects associated with antidepressant withdrawal. Accordingly, an electronic search of the PubMed/MedLine database and Google Scholar was conducted to find relevant literature published within the last 10 years. From this, 18 related articles were identified; five clinical studies, one case series, one consensus panel’s recommendations and 11 literature reviews. Of the articles reviewed there is a general consensus as to tapering the drug slowly over a period of weeks or months. Also, in those patients who experience severe symptoms the drug should be reinstated and discontinued more gradually. The discontinuation syndrome does not occur as frequently or severely with longer-acting agents such as fluoxetine and therefore it is recommended that switching to this drug prior to withdrawal may be advisable. The articles reviewed also emphasize the need for patient education and reassurance throughout the discontinuation process. One in particular adds that cognitive behavioural therapy may be a useful tool in easing the patients’ distress. However, this review highlights the lack of controlled data to support the available guidelines. Furthermore, the guidance which is available is somewhat conflicting. Research approaches should address this issue as well as develop appropriate methods of withdrawal for specific drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/2045125315612334

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 13

  1. Black K., 2000, J Psychiatry Neurosci, 25, 255
  2. Coryell W. (2013) Depressive disorders. Merck Manuals Professional Edition. Available at: http://www.merckmanuals.com/professional/psychiatric_disorders/mood_disorders/depressive_disorders.html#v1028131 (accessed 25 August 2014).
  3. Gartlehner G., 2011, Comparative Effectiveness Reviews
  4. Groot P., 2013, Tijdschr Psychiatr, 55, 789
  5. Haddad P., 2007, APT, 13, 447
  6. Joffe R., 2006, J Psychiatry Neurosci, 31, 11
  7. Lieberman J., 2003, J Clin Psychiatry, 5, 6
  8. Muzina D., 2010, Curr Psychiatry, 9, 50
  9. Renoir T., 2013, Front Pharmacol, 16, 45
  10. Schatzberg A., 2006, J Clin Psychiatry, 67, 27
  11. Schatzberg A., 1997, J Clin Psychiatry, 58, 23
  12. Warner C., 2006, Am Fam Physician, 74, 449
  13. Wiese B., 2011, BCMJ, 53, 341

Cited by

See all 111

Metadata

Authors
Wilson, E., & Lader, M.
Affiliations
King's College London (GB)
Corresponding author
Wilson, Emma
Venue
Therapeutic Advances in Psychopharmacology
Published
2015-10-28
Volume
5
Issue
6
Pages
357-368
ISSN
  • 2045-1253 (ISSN-L)
  • 2045-1261
OpenAlex
W2296227733
Cited by
103
References
52
Citations by year
2026: 3 · 2025: 10 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 8 · 2020: 14 · 2019: 14 · 2018: 15 · 2017: 12 · 2016: 4
FWCI
1.30
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Therapeutic Advances in Psychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • King's College London
  • Institute of Psychiatry, Psychology and Neuroscience, King’s College London
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords
antidepressant discontinuation syndrome, antidepressant discontinuation, second-generation antidepressants, gradual tapering, fluoxetine, patient education, cognitive behavioral therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A review of the management of antidepressant discontinuation symptoms. https://app.cochat.ai/papers/10.1177/2045125315612334
The paper
Wilson, E., & Lader, M. (2015). A review of the management of antidepressant discontinuation symptoms. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125315612334

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.